First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

529 Reviews

Credit Rating - DR KASHKOULI CLINIC LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: DR KASHKOULI CLINIC LIMITED, XEINADIN CORPORATE RECOVERY LIMITED, 100 BARBIROLLI SQUARE, MANCHESTER, M2 3BD. The legal status is a Private Limited Company and the current status at the registry of companies is Liquidation. The last filed accounts are dated 31 March 2022. The company was incorporated on 28 March 2007.

The accounts next due date is 31 December 2023. There are no mortgages.

The above was based on public record information as at 18 February 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 06188986
Date Incorporated: 28 March 2007
Date Latest Accounts: 31 March 2022
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: SOLHAN FASHIONS LIMITED
Registered Number: 06188986
Annual Return: 28 March 2016
Registered Office: XEINADIN CORPORATE RECOVERY LIMITED, 100 BARBIROLLI SQUARE, MANCHESTER, M2 3BD
SIC Code and Operations: 86230
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

DR KASHKOULI CLINIC LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 28 February 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
14483218 DR KASIM LTD Active
14958924 DR KAT AESTHETIC CLINIC LIMITED Active
15531540 DR KAT LIMITED Active
09394804 DR KATE AESTHETICS LTD Active - Proposal to Strike off
09683391 DR KATE ALEXANDRA AESTHETICS LTD Active

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd